No Data
No Data
In the first quarter, Yaokang Bio (688046.SH) reported a Net income of 29.9803 million yuan, a year-on-year increase of 1.7%.
On April 26, Gelonghui reported that Yaokang Biological (688046.SH) released its quarterly report, achieving a total operating revenue of 0.171 billion yuan in the first quarter of 2025, a year-on-year increase of 8.76%; net income attributable to shareholders of the parent company was 29.9803 million yuan, a year-on-year increase of 1.7%; and the basic EPS was 0.07 yuan.
Yakkang Biotech\'s 2025 First Quarter Report
Yakkang Biotech 2024 Annual Report
Summary of Yakkang Biotech\'s 2024 Annual Report
Express News | Next week, more than 84 billion yuan worth of Stocks will be released from restrictions, which will double the circulating shares of these Stocks.
GemPharmatech Significantly Expands U.S. Capabilities With New San Diego Biotech Hub Facility